摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,4-bis-chloroacetyl-1,3,5-trimethyl-benzene | 156641-43-9

中文名称
——
中文别名
——
英文名称
2,4-bis-chloroacetyl-1,3,5-trimethyl-benzene
英文别名
2,4-Bis-chloracetyl-1,3,5-trimethyl-benzol;eso-Bis-chloracetyl-mesitylen;1,3-bis(chloroacetyl)-2,4,6-trimethylbenzene;2-Chloro-1-[3-(2-chloro-acetyl)-2,4,6-trimethyl-phenyl]-ethanone;2-chloro-1-[3-(2-chloroacetyl)-2,4,6-trimethylphenyl]ethanone
2,4-bis-chloroacetyl-1,3,5-trimethyl-benzene化学式
CAS
156641-43-9
化学式
C13H14Cl2O2
mdl
MFCD06654903
分子量
273.159
InChiKey
MXERVPDGZHBHCZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    419.1±45.0 °C(Predicted)
  • 密度:
    1.218±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    17
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.384
  • 拓扑面积:
    34.1
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

点击查看最新优质反应信息

文献信息

  • Process for preparation of arenebisphosphine oxides
    申请人:BASF Aktiengesellschaft
    公开号:US05410060A1
    公开(公告)日:1995-04-25
    Arenebisphosphine oxides of the general formula ##STR1## where R.sup.1 to R.sup.4 independently of one another are each hydrogen, C.sub.1 -C.sub.6 -alkyl, C.sub.1 -C.sub.6 -alkoxy, C.sub.5 -C.sub.10 -aryl, C.sub.5 -C.sub.12 -aryloxy or C.sub.7-C.sub.14 -arylalkoxy, R.sup.5 and R.sup.6 independently of one another may each be C.sub.1 -C.sub.6 -alkyl, C.sub.5 -C.sub.10 -cycloalkyl or C.sub.5 -C.sub.12 -aryl, each of which may furthermore contain one or two nitrogen or sulfur atoms in the ring system or carry one or two halogen atoms or C.sub.1 -C.sub.6 -alkyl or C.sub.1 -C.sub.6 -alkoxy groups as substituent on the ring system, or C.sub.1 -C.sub.6 -alkoxy, C.sub.3 -C.sub.8 -alkoxyalkoxy, C.sub.5 -C.sub.12 -aryloxy or C.sub.7 -C.sub.14 -arylalkoxy, or R.sup.5 and R.sup.6 together form a bridge of 2 to 10 carbon atoms, in which some of the carbon atoms may furthermore be part of an aromatic ring.
    阿伦磷氧化物的一般化学式为##STR1## 其中R.sup.1至R.sup.4分别独立地为氢、C.sub.1-C.sub.6-烷基、C.sub.1-C.sub.6-烷氧基、C.sub.5-C.sub.10-芳基、C.sub.5-C.sub.12-芳氧基或C.sub.7-C.sub.14-芳基烷氧基,R.sup.5和R.sup.6分别独立地可以是C.sub.1-C.sub.6-烷基、C.sub.5-C.sub.10-环烷基或C.sub.5-C.sub.12-芳基,其中每个基可能还含有一个或两个氮或硫原子在环系中,或携带一个或两个卤原子或C.sub.1-C.sub.6-烷基或C.sub.1-C.sub.6-烷氧基基团作为环系上的取代基,或C.sub.1-C.sub.6-烷氧基、C.sub.3-C.sub.8-烷氧基烷氧基、C.sub.5-C.sub.12-芳氧基或C.sub.7-C.sub.14-芳基烷氧基,或R.sup.5和R.sup.6一起形成2到10个碳原子的桥梁,其中一些碳原子可能还是芳环的一部分。
  • Arenbisphosphinoxide
    申请人:BASF Aktiengesellschaft
    公开号:EP0601413A1
    公开(公告)日:1994-06-15
    Arenbisphosphinoxide der allgemeinen Formel worin die Reste R¹ bis R⁴ unabhängig voneinander für ein Wasserstoffatom oder eine C₁-C₆-Alkyl-, -Alkoxygruppe oder eine C₅-C₁₀-Aryl-, eine C₅-C₁₂-Aryloxy- oder eine C₇-C₁₄-Arylalkoxygruppe stehen, R⁵ und R⁶ unabhängig voneinander für eine C₁-C₆-Alkylgruppe, eine C₅-C₁₀-Cycloalkylgruppe oder eine C₅-C₁₂-Arylgruppe, welche auch ein oder zwei Stickstoff- oder Schwefelatome im Ringsystem enthalten oder ein oder zwei Halogenatome, C₁-C₆-Alkyl- oder - Alkoxygruppen als Substituenten am Ringsystem tragen können oder für eine C₁-C₆-Alkoxy-, eine C₃-C₈-Alkyloxyalkoxy-, eine C₅-C₁₂-Aryloxy- oder C₇₋C₁₄-Arylalkoxygruppe stehen können oder R⁵ und R⁶ gemeinsam eine Brücke aus 2 bis 10 Kohlenstoffatomen bilden, wobei auch ein Teil der Kohlenstoffatome Bestandteil eines aromatischen Rings sein kann.
    通式为烯丙基双膦氧化物 其中基 R¹ 至 R⁴ 相互独立地代表氢原子或 C₁-C₆ 烷基、-烷氧基或 C₅-C₁₀ 芳基、C₅-C₁₂ 芳氧基或 C₇-C₁₄- 芳基烷氧基、R⁵ 和 R⁶ 相互独立地代表 C₁-C₆-烷基、C₅-C₁₀-环烷基或 C₅-C₁₂-芳基,它们在环系中还含有一个或两个氮原子或硫原子或一个或两个卤素原子、C₅-C₁₂芳氧基或 C₇₋C₁₄芳烷氧基或 R⁵ 和 R⁶ 共同形成 2 至 10 个碳原子的桥,其中一些碳原子也可以是芳香环的一部分。
  • Breed, Bryn Mawr College Monographs 1, No. 1, S. 11
    作者:Breed
    DOI:——
    日期:——
  • Polyphosphoric Acid as a Dehydrating Agent. III. Identification of the Hydrocarbons from Mesitylene and Aliphatic Acids<sup>1</sup>
    作者:H. R. Snyder、Roger W. Roeske
    DOI:10.1021/ja01143a004
    日期:1952.12
  • Autoimmune thyroiditis in non-obese subjects with initial diagnosis of Type 2 diabetes mellitus
    作者:M. Matějková-Běhanová、V. Zamrazil、K. Vondra、J. Vrbíková、P. Kučera、M. Hill、M. Anděl
    DOI:10.1007/bf03345512
    日期:2002.10
    Autoimmune thyroiditis is often associated with Type 1 diabetes mellitus (T1DM). In non-obese adult-onset diabetes diagnosed initially as Type 2 diabetes mellitus (T2DM), there is a proportion of cases with so far undiagnosed T1DM. The objective of this study was to estimate the frequency of autoimmune thyroiditis (AT) among non-obese (BMI <30.0 kg/m2) patients with T2DM and to compare the frequency of AT in subgroups of patients according to the presence of glutamic acid decarboxylase antibodies (GADA), insulin requirement, and post-breakfast C-peptide levels. The study included 118 adult patients (55 men and 63 women) with the initial diagnosis of T2DM and age at the onset of diabetes > 35 yr. Median of age was 66 yr (range 39-82), and median duration of diabetes was 9 (range 1-27) yr. AT was diagnosed using thyroid peroxidase antibodies, TG-antibodies, US and TSH levels. Nineteen per cent of the subjects were found to have AT, and the frequency of AT did not significantly differ between the groups of GADA+ and GADA- subjects. There was no difference in the frequency of AT between the group treated with hypoglycemic agents and/or diet and the group requiring insulin. The frequency of AT was higher in the group with post-breakfast C-peptide levels < or = 0.8 nmol/l compared to the group with post-breakfast C-peptide levels > 0.8 nmol/l (37% vs 16%), however the group with post-breakfast C-peptide levels < or = 0.8 nmol/l had longer duration of diabetes.
查看更多